A Phase 1 trial found that a freeze-dried, temperature-stable experimental tuberculosis vaccine was safe, well-tolerated and elicited robust antigen-specific serum antibody and Th1-type cellular immune responses.
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found it prompted immune response and was safe.
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found it prompted immune response and was safe.
Currently, Bacille Calmette-Guerin (BCG) is the most widely administered vaccine against TB across the globe. Nearly 100 years old, it is the only vaccine ever administered to treat TB, which afflicts more than 10 million people each year.In t
A novel vaccine against deadly tuberculosis (TB) has shown to be safe and effective, according to results of the Phase 1 clinical trial.Currently, Bacille Calmette-Guerin (BCG) is the most widely administered vaccine against TB across the .